Cargando…

Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease

Predicting progression of mild cognitive impairment (MCI) to Alzheimer’s disease (AD) is clinically important. In this study, we propose a dual-model radiomic analysis with multivariate Cox proportional hazards regression models to investigate promising risk factors associated with MCI conversion to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Hucheng, Jiang, Jiehui, Lu, Jiaying, Wang, Min, Zhang, Huiwei, Zuo, Chuantao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338093/
https://www.ncbi.nlm.nih.gov/pubmed/30686995
http://dx.doi.org/10.3389/fnins.2018.01045
_version_ 1783388397830668288
author Zhou, Hucheng
Jiang, Jiehui
Lu, Jiaying
Wang, Min
Zhang, Huiwei
Zuo, Chuantao
author_facet Zhou, Hucheng
Jiang, Jiehui
Lu, Jiaying
Wang, Min
Zhang, Huiwei
Zuo, Chuantao
author_sort Zhou, Hucheng
collection PubMed
description Predicting progression of mild cognitive impairment (MCI) to Alzheimer’s disease (AD) is clinically important. In this study, we propose a dual-model radiomic analysis with multivariate Cox proportional hazards regression models to investigate promising risk factors associated with MCI conversion to AD. T1 structural magnetic resonance imaging (MRI) and (18)F-Fluorodeoxyglucose (FDG) positron emission tomography (PET) data, from the AD Neuroimaging Initiative database, were collected from 131 patients with MCI who converted to AD within 3 years and 132 patients with MCI without conversion within 3 years. These subjects were randomly partition into 70% training dataset and 30% test dataset with multiple times. We fused MRI and PET images by wavelet method. In a subset of subjects, a group comparison was performed using a two-sample t-test to determine regions of interest (ROIs) associated with MCI conversion. 172 radiomic features from ROIs for each individual were established using a published radiomics tool. Finally, L1-penalized Cox model was constructed and Harrell’s C index (C-index) was used to evaluate prediction accuracy of the model. To evaluate the efficacy of our proposed method, we used a same analysis framework to evaluate MRI and PET data separately. We constructed prognostic Cox models with: clinical data, MRI images, PET images, fused MRI/PET images, and clinical variables and fused MRI/PET images in combination. The experimental results showed that captured ROIs significantly associated with conversion to AD, such as gray matter atrophy in the bilateral hippocampus and hypometabolism in the temporoparietal cortex. Imaging model (MRI/PET/fused) provided significant enhancement in prediction of conversion compared to clinical models, especially the fused-modality Cox model. Moreover, the combination of fused-modality imaging and clinical variables resulted in the greatest accuracy of prediction. The average C-index for the clinical/MRI/PET/fused/combined model in the test dataset was 0.69, 0.73, 0.73 and 0.75, and 0.78, respectively. These results suggested that a combination of radiomic analysis and Cox model analyses could be used successfully in survival analysis and may be powerful tools for personalized precision medicine patients with potential to undergo conversion from MCI to AD.
format Online
Article
Text
id pubmed-6338093
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63380932019-01-25 Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease Zhou, Hucheng Jiang, Jiehui Lu, Jiaying Wang, Min Zhang, Huiwei Zuo, Chuantao Front Neurosci Neuroscience Predicting progression of mild cognitive impairment (MCI) to Alzheimer’s disease (AD) is clinically important. In this study, we propose a dual-model radiomic analysis with multivariate Cox proportional hazards regression models to investigate promising risk factors associated with MCI conversion to AD. T1 structural magnetic resonance imaging (MRI) and (18)F-Fluorodeoxyglucose (FDG) positron emission tomography (PET) data, from the AD Neuroimaging Initiative database, were collected from 131 patients with MCI who converted to AD within 3 years and 132 patients with MCI without conversion within 3 years. These subjects were randomly partition into 70% training dataset and 30% test dataset with multiple times. We fused MRI and PET images by wavelet method. In a subset of subjects, a group comparison was performed using a two-sample t-test to determine regions of interest (ROIs) associated with MCI conversion. 172 radiomic features from ROIs for each individual were established using a published radiomics tool. Finally, L1-penalized Cox model was constructed and Harrell’s C index (C-index) was used to evaluate prediction accuracy of the model. To evaluate the efficacy of our proposed method, we used a same analysis framework to evaluate MRI and PET data separately. We constructed prognostic Cox models with: clinical data, MRI images, PET images, fused MRI/PET images, and clinical variables and fused MRI/PET images in combination. The experimental results showed that captured ROIs significantly associated with conversion to AD, such as gray matter atrophy in the bilateral hippocampus and hypometabolism in the temporoparietal cortex. Imaging model (MRI/PET/fused) provided significant enhancement in prediction of conversion compared to clinical models, especially the fused-modality Cox model. Moreover, the combination of fused-modality imaging and clinical variables resulted in the greatest accuracy of prediction. The average C-index for the clinical/MRI/PET/fused/combined model in the test dataset was 0.69, 0.73, 0.73 and 0.75, and 0.78, respectively. These results suggested that a combination of radiomic analysis and Cox model analyses could be used successfully in survival analysis and may be powerful tools for personalized precision medicine patients with potential to undergo conversion from MCI to AD. Frontiers Media S.A. 2019-01-11 /pmc/articles/PMC6338093/ /pubmed/30686995 http://dx.doi.org/10.3389/fnins.2018.01045 Text en Copyright © 2019 Zhou, Jiang, Lu, Wang, Zhang, Zuo and the Alzheimer’s Disease Neuroimaging Initiative. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Zhou, Hucheng
Jiang, Jiehui
Lu, Jiaying
Wang, Min
Zhang, Huiwei
Zuo, Chuantao
Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease
title Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease
title_full Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease
title_fullStr Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease
title_full_unstemmed Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease
title_short Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease
title_sort dual-model radiomic biomarkers predict development of mild cognitive impairment progression to alzheimer’s disease
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338093/
https://www.ncbi.nlm.nih.gov/pubmed/30686995
http://dx.doi.org/10.3389/fnins.2018.01045
work_keys_str_mv AT zhouhucheng dualmodelradiomicbiomarkerspredictdevelopmentofmildcognitiveimpairmentprogressiontoalzheimersdisease
AT jiangjiehui dualmodelradiomicbiomarkerspredictdevelopmentofmildcognitiveimpairmentprogressiontoalzheimersdisease
AT lujiaying dualmodelradiomicbiomarkerspredictdevelopmentofmildcognitiveimpairmentprogressiontoalzheimersdisease
AT wangmin dualmodelradiomicbiomarkerspredictdevelopmentofmildcognitiveimpairmentprogressiontoalzheimersdisease
AT zhanghuiwei dualmodelradiomicbiomarkerspredictdevelopmentofmildcognitiveimpairmentprogressiontoalzheimersdisease
AT zuochuantao dualmodelradiomicbiomarkerspredictdevelopmentofmildcognitiveimpairmentprogressiontoalzheimersdisease
AT dualmodelradiomicbiomarkerspredictdevelopmentofmildcognitiveimpairmentprogressiontoalzheimersdisease